Scienture Holdings | 8-K: Current report
Scienture Holdings | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Scienture Holdings | 8-K: Current report
Scienture Holdings | DEF 14C: Definitive information statements
Scienture Holdings | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition
Scienture Holdings | D: Filing D
Scienture Holdings | S-1: General form for registration of securities under the Securities Act of 1933
Scienture Holdings | 8-K: Current report
Scienture Holdings | 1-A/A: Others
Scienture Holdings | 10-Q: Q3 2024 Earnings Report
Scienture Holdings | 8-K: Current report
Scienture Holdings | 8-K: Current report
1-A: Others
8-K: Current report
Trxade Health | DEF 14C: Definitive information statements
Trxade Health | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition
Trxade Health | 10-Q: Q2 2024 Earnings Report
Trxade Health | 3: Initial statement of beneficial ownership of securities-Director Shankar Hariharan
Trxade Health | 3: Initial statement of beneficial ownership of securities-Director Narasimhan Mani
Trxade Health | 8-K: Current report